146256-98-6 Usage
Description
Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate, also known as 1-tert-butyl 3-ethyl 4-oxopyrrolidine-1,3-dicarboxylate, is a white to slightly yellow crystalline powder. It is a valuable research chemical with unique chemical properties that make it suitable for various applications in different industries.
Uses
Used in Pharmaceutical Industry:
Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows for the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
As a research chemical, Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate is used in the development and testing of new chemical reactions and processes. Its properties make it a valuable tool for understanding the behavior of similar compounds and for advancing the field of organic chemistry.
Used in Material Science:
Ethyl N-Boc-4-Oxopyrrolidine-3-carboxylate may also find applications in the field of material science, where its unique properties can be utilized to develop new materials with specific characteristics, such as improved stability or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 146256-98-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,2,5 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 146256-98:
(8*1)+(7*4)+(6*6)+(5*2)+(4*5)+(3*6)+(2*9)+(1*8)=146
146 % 10 = 6
So 146256-98-6 is a valid CAS Registry Number.
InChI:InChI=1/C12H19NO5/c1-5-17-10(15)8-6-13(7-9(8)14)11(16)18-12(2,3)4/h8H,5-7H2,1-4H3
146256-98-6Relevant articles and documents
BICYCLIC AMINES AS NOVEL JAK KINASE INHIBITORS
-
, (2018/08/12)
The present invention relates to a compound according to formula (I) wherein R1 represents alkyl; n is 1 or 2; R2 is selected from the group consisting of hydrogen, cyano, -SO2Ra, -SO2NRbR
Preparation method for omarigliptin midbody
-
Paragraph 0030-0032, (2017/07/19)
The invention provides an efficient and simple preparation method for omarigliptin midbody pyrrole and [3,4-c] pyrazol-5(2H,4H,6H)-carboxylic acid tert-butyl ester, wherein the total recovery ratio is close to 50%. The preparation method is easy to operate, the recovery ratio is higher, three produced wastes are less, and the method is suitable for industrialized production.
ANTI-ANGIOGENESIS COMPOUND, INTERMEDIATE AND USE THEREOF
-
Paragraph 0155; 0158; 0161-0162, (2016/11/02)
Disclosed are an anti-abnormal proliferation of angiogenesis compound represented by formula I, use and intermediate thereof. The compound has good effect against abnormal proliferation of angiogenesis, and the activity of the compound is produced by inhibiting VEGFR2. The compound can be used for treating diseases, such as wet macular degeneration, inflammation, malignant tumor and the like, caused by abnormity of angiogenesis and protein kinases such as VEGFR2, FGFR2 and the like.